Join to View Full Profile
2959 Sharpsburg McCullum RdNewnan, GA 30265
Phone+1 770-502-2000
Fax+1 770-502-2049
Dr. Stark is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Emory University School of MedicineFellowship, Rheumatology, 2006 - 2008- Emory University School of MedicineResidency, Internal Medicine, 2003 - 2006
Vanderbilt University School of MedicineClass of 2003
Certifications & Licensure
GA State Medical License 2006 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (FACR) American College of Rheumatology
Publications & Presentations
PubMed
- Certolizumab Pegol Treatment in Patients With Crohn's Disease: Final Safety Data From the SECURE Registry.Gary R Lichtenstein, Scott D Lee, Brian G Feagan, Edward V Loftus Jr, Samson Ng
Crohn's & Colitis 360. 2025-01-01 - Impact of Disease Burden of Patients with Psoriasis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry.Andrew Blauvelt, Robert R McLean, Silky W Beaty, Adam P Sima, Robert Low
Dermatology and Therapy. 2024-10-01 - 2 citationsMental health outcomes in patients with moderate to severe psoriasis treated with bimekizumab: Analysis of phase 2/3 randomized trials.Andrew Blauvelt, April Armstrong, Joseph F Merola, Bruce Strober, Dirk de Cuyper
Journal of the American Academy of Dermatology. 2024-07-01
Press Mentions
UCSF-Led Study Aims to Improve Treatment of Painful Skin DiseaseDecember 20th, 2024- Non-Radiographic Axial Spondyloarthritis Recognized with ICD-10 CodeAugust 21st, 2020
- UCB Announces U.S. Availability of BIMZELX® for the Treatment of Adults with Moderate-to-Severe Plaque PsoriasisNovember 16th, 2023
- Join now to see all
Professional Memberships
- Fellow
Industry Relationships
- Head of Medical Affairs, Rheumatology, UCB, Inc.2014 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
